Oklo, which is chaired by Open AI’s Sam Altman, signed a non-binding agreement with Switch Inc, a large privately held data centre operator, to build reactors with a total capacity of up to 12 ...

We recently compiled a list of the 13 Cheap High Dividend Stocks To Invest In Now. In this article, we are going to take a ...

According to Deutsche Bank Wealth Management, the global economy in 2025 is expected to face some tough challenges, with growth forecasts looking modest – the US GDP at 2.0%, the Eurozone at 0.9%, ...

Citadel’s deputy head of Asia fundamental equities Takeo Serizawa left the company after about 21 months at the investment ...

AI mania has taken the world by storm, with the game-changing tech seemingly poised to permeate almost every aspect of our ...

Ken Griffin's Citadel hedge fund places £305M short bet against GSK, with skepticism over long-term pipeline and recent stock ...

After years of limping along, the GSK share price has leapt 11% in one month. But one of America's richest investors is ...

(Alliance News) - Hedge fund Citadel has made a GBP305 million bet against pharmaceuticals firm GSK PLC, the biggest short position against the company in more than a decade, according to the ...

Citadel, the hedge fund owned by billionaire Ken Griffin, has taken a short position in GlaxoSmithKline (NYSE:GSK), a British ...

Billionaire Ken Griffin's hedge fund Citadel has taken a short position in British drugmaker GSK , the Financial Times ...

Hedge fund Citadel has made a £305mn bet against drugmaker GSK, the biggest short position against the company in more than a decade.

The Citadel founder says that the US will lose out on international trade and the AI arms race as a result.